U.S. Injectable Cytotoxic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Alkylating Drugs, Cytotoxic Antibodies, Antimetabolites, Plant Alkaloids, and Others), By Application (Oncology, Rheumatoid Arthritis, Multiple Sclerosis, and Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Country Forecast, 2023-2030

Last Updated: January 27, 2025 | Format: PDF | Report ID: FBI109024

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 4.5% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Drug Class Alkylating Drugs Cytotoxic Antibodies Antimetabolites Plant Alkaloids Others
	By Application Oncology Rheumatoid Arthritis Multiple Sclerosis Others
	By Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy